Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation.

Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation.

Show other versions (1)

Bibliographic Details
Main Authors:	Burls, A, Clark, W, Stewart, T, Preston, C, Bryan, S, Jefferson, T, Fry-Smith, A
Format:	Journal article
Language:	English
Published:	2002

Similar Items

Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation.
by: Burls, A, et al.
Published: (2002)

Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation
by: A. Burls, et al.
Published: (2002-01-01)

Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments.
by: Heneghan, C, et al.
Published: (2014)

Intravenous zanamivir for influenza myocarditis and enteral malabsorption
by: Fritz-Patrick Jahns, et al.
Published: (2018-12-01)

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness
by: Chen, Y, et al.
Published: (2006)

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
by: Chen, Y, et al.
Published: (2006)

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness
by: Y-F Chen, et al.
Published: (2006-11-01)

Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation
by: P Tappenden, et al.
Published: (2008-02-01)

Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease.
by: Clark, W, et al.
Published: (2003)

Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease.
by: Clark, W, et al.
Published: (2003)

Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease
by: W. Clark, et al.
Published: (2003-01-01)

Permeability enhancers dramatically increase zanamivir absolute bioavailability in rats: implications for an orally bioavailable influenza treatment.
by: Eric H Holmes, et al.
Published: (2013-01-01)

A systematic review of effectiveness and economic evaluation of new drug treatments for juvenile idiopathic arthritis: etanercept.
by: Cummins, C, et al.
Published: (2002)

A systematic review of effectiveness and economic evaluation of new drug treatments for juvenile idiopathic arthritis: etanercept.
by: Cummins, C, et al.
Published: (2002)

Quantification of the anti-influenza drug zanamivir in plasma using high-throughput HILIC-MS/MS.
by: Lindegardh, N, et al.
Published: (2011)

Polymer-attached zanamivir inhibits synergistically both early and late stages of influenza virus infection
by: Lee, Chia Min, et al.
Published: (2013)

The Intranasal Application of Zanamivir and Carrageenan Is Synergistically Active against Influenza A Virus in the Murine Model.
by: Martina Morokutti-Kurz, et al.
Published: (2015-01-01)

Systemic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease
by: Clark, W, et al.
Published: (2003)

Successful Treatment of Complicated Influenza A(H3N2) Virus Infection and Rhabdomyolysis with Compassionate Use of IV Zanamivir
by: Maren Alchikh, et al.
Published: (2023-01-01)

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.
by: Clark, W, et al.
Published: (2004)

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.
by: Clark, W, et al.
Published: (2004)

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis
by: Clark, W, et al.
Published: (2004)

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis
by: W Clark, et al.
Published: (2004-09-01)

The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation.
by: Jobanputra, P, et al.
Published: (2002)

The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: A systematic review and economic evaluation
by: Jobanputra, P, et al.
Published: (2002)

The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation
by: P. Jobanputra, et al.
Published: (2002-01-01)

Study of oseltamivir and zanamivir resistance-related mutations in influenza viruses isolated from wild mallards in Sweden.
by: Goran Orozovic, et al.
Published: (2014-01-01)

An open-label crossover study to evaluate potential pharmacokinetic interactions between oral oseltamivir and intravenous zanamivir in healthy Thai adults.
by: Pukrittayakamee, S, et al.
Published: (2011)

An open-label crossover study to evaluate potential pharmacokinetic interactions between oral oseltamivir and intravenous zanamivir in healthy thai adults
by: Pukrittayakamee, S, et al.
Published: (2011)

Neuraminidase Inhibitor Zanamivir Ameliorates Collagen-Induced Arthritis
by: Bettina Sehnert, et al.
Published: (2021-01-01)

Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial.
by: Xavier Duval, et al.
Published: (2010-11-01)

Detection of resistance mutations to antivirals oseltamivir and zanamivir in avian influenza A viruses isolated from wild birds.
by: Goran Orozovic, et al.
Published: (2011-01-01)

Efficacy of oseltamivir compared with zanamivir in COPD patients with seasonal influenza virus infection: a randomized controlled trial
by: Min Li, et al.
Published: (2020-11-01)

Zanamivir Conjugated to Poly-L-Glutamine is Much More Active Against Influenza Viruses in Mice and Ferrets Than the Drug Itself
by: Belser, Jessica A., et al.
Published: (2014)

Attaching zanamivir to a polymer markedly enhances its activity against drug-resistant strains of influenza a virus
by: Weight, Alisha Kessel, et al.
Published: (2012)

Correction: Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial.
by: Xavier Duval, et al.
Published: (2010-12-01)

El zanamivir inhalado es eficaz en la profilaxis post-exposición de la influenza en adultos
by: Gabriela Fabbro
Published: (2001-09-01)

Treatments for fatigue in multiple sclerosis: a rapid and systematic review.
by: Brañas, et al.
Published: (2000-01-01)

In Silico Studies Reveal Peramivir and Zanamivir as an Optimal Drug Treatment Even If H7N9 Avian Type Influenza Virus Acquires Further Resistance
by: Edita Sarukhanyan, et al.
Published: (2022-09-01)

Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation
by: J Burch, et al.
Published: (2009-11-01)